Naomi Laing

Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)

Yung‐Jue Bang, Talia Golan, Laëtitia Dahan et al. · European Journal of Cancer · 2020 · 133 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive <i>TP53</i> -mutant Ovarian Cancer

Amit M. Oza, Maria Del Pilar Estevez-Diz, Eva‐Maria Grischke et al. · Clinical Cancer Research · 2020 · 123 citations · Full text

Medicine, Oncology, Pharmacology +16

Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)

Edward J. Hennessy, Ammar Adam, Brian Aquila et al. · Journal of Medicinal Chemistry · 2013 · 115 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells.

Naomi Laing, Martin G. Belinsky, Gary D. Kruh et al. · PubMed · 1998 · 85 citations

Medicine, Genetics, Oncology +13

Interaction of Estramustine with Tubulin Isotypes

Naomi Laing, Björn Dahllöf, Beryl Hartley‐Asp et al. · Biochemistry · 1997 · 68 citations

Life Sciences, Biochemistry, Pharmacology +16